AR100334A1 - Solución oftálmica acuosa y método para tratar el síndrome del ojo seco - Google Patents

Solución oftálmica acuosa y método para tratar el síndrome del ojo seco

Info

Publication number
AR100334A1
AR100334A1 ARP150101388A ARP150101388A AR100334A1 AR 100334 A1 AR100334 A1 AR 100334A1 AR P150101388 A ARP150101388 A AR P150101388A AR P150101388 A ARP150101388 A AR P150101388A AR 100334 A1 AR100334 A1 AR 100334A1
Authority
AR
Argentina
Prior art keywords
ophthalmic solution
container
salts
container containing
dry eye
Prior art date
Application number
ARP150101388A
Other languages
English (en)
Inventor
Prinz Martin
Original Assignee
Croma-Pharma Ges M B H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=50693490&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR100334(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Croma-Pharma Ges M B H filed Critical Croma-Pharma Ges M B H
Publication of AR100334A1 publication Critical patent/AR100334A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/05—Containers specially adapted for medical or pharmaceutical purposes for collecting, storing or administering blood, plasma or medical fluids ; Infusion or perfusion containers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/05—Containers specially adapted for medical or pharmaceutical purposes for collecting, storing or administering blood, plasma or medical fluids ; Infusion or perfusion containers
    • A61J1/10—Bag-type containers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14—Details; Accessories therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14—Details; Accessories therefor
    • A61J1/1468—Containers characterised by specific material properties
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/722—Chitin, chitosan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/06—Macromolecular compounds, carriers being organic macromolecular compounds, i.e. organic oligomeric, polymeric, dendrimeric molecules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/04—Artificial tears; Irrigation solutions
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D65/00—Wrappers or flexible covers; Packaging materials of special type or form
    • B65D65/38—Packaging materials of special type or form
    • B65D65/40—Applications of laminates for particular packaging purposes
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D81/00—Containers, packaging elements, or packages, for contents presenting particular transport or storage problems, or adapted to be used for non-packaging purposes after removal of contents
    • B65D81/24—Adaptations for preventing deterioration or decay of contents; Applications to the container or packaging material of food preservatives, fungicides, pesticides or animal repellants
    • B65D81/26—Adaptations for preventing deterioration or decay of contents; Applications to the container or packaging material of food preservatives, fungicides, pesticides or animal repellants with provision for draining away, or absorbing, or removing by ventilation, fluids, e.g. exuded by contents; Applications of corrosion inhibitors or desiccators
    • B65D81/266—Adaptations for preventing deterioration or decay of contents; Applications to the container or packaging material of food preservatives, fungicides, pesticides or animal repellants with provision for draining away, or absorbing, or removing by ventilation, fluids, e.g. exuded by contents; Applications of corrosion inhibitors or desiccators for absorbing gases, e.g. oxygen absorbers or desiccants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Ophthalmology & Optometry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Optics & Photonics (AREA)
  • Physics & Mathematics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Mechanical Engineering (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)

Abstract

Una solución oftálmica acuosa estéril que comprende de aproximadamente 0,05% a aproximadamente 0,5% (peso/peso) de N-(N-acetilcisteinil)quitosano o una de sus sales farmacéuticamente aceptables en una solución portadora, en donde el N-(N-acetilcisteinil)quitosano tiene un contenido de grupos tiol libres en una cantidad de 80 mmol/g de polímero a 280 mmol/g de polímero. Contenedor que contiene dicha solución oftálmica, así como también al uso de ésta en la prevención o tratamiento del síndrome del ojo seco o de los signos y/o síntomas de ojos secos. Reivindicación 6: La solución oftálmica de acuerdo con cualquiera de las reivindicaciones anteriores, caracterizada porque comprende además al menos un excipiente seleccionado de entre el grupo consistente en ácido bórico y sus sales, sales de ácido cítrico, sales de ácidos acético, polietilenglicol, Na₂-EDTA, manitol, sorbitol, glicerol, cloruro de sodio, metabisulfito de sodio, hidroxipropilmetilcelulosa, polivinilpirrolidona, alcohol polivinílico, lubricina, ácido hialurónico y sus sales farmacéuticamente aceptables o sus mezclas. Reivindicación 11: Contenedor caracterizado porque comprende una solución oftálmica de acuerdo con cualquiera de las reivindicaciones anteriores bajo una atmósfera esencialmente libre de oxígeno. Reivindicación 12: Contenedor de acuerdo con la reivindicación 11, caracterizado porque comprende un primer contenedor que contiene la solución oftálmica y un segundo contenedor que contiene dicho primer contenedor.
ARP150101388A 2014-05-07 2015-05-07 Solución oftálmica acuosa y método para tratar el síndrome del ojo seco AR100334A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP14167381 2014-05-07

Publications (1)

Publication Number Publication Date
AR100334A1 true AR100334A1 (es) 2016-09-28

Family

ID=50693490

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP150101388A AR100334A1 (es) 2014-05-07 2015-05-07 Solución oftálmica acuosa y método para tratar el síndrome del ojo seco

Country Status (28)

Country Link
US (2) US10342759B2 (es)
EP (1) EP3139903B1 (es)
JP (1) JP6639480B2 (es)
KR (1) KR102378391B1 (es)
CN (1) CN106456536B (es)
AR (1) AR100334A1 (es)
AU (1) AU2015257874B2 (es)
BR (1) BR112016024454B1 (es)
CA (1) CA2947065C (es)
CL (1) CL2016002815A1 (es)
CY (1) CY1122122T1 (es)
DK (1) DK3139903T3 (es)
ES (1) ES2747808T3 (es)
HR (1) HRP20191667T1 (es)
HU (1) HUE046425T2 (es)
IL (1) IL248804B (es)
LT (1) LT3139903T (es)
MA (1) MA39767B1 (es)
ME (1) ME03505B (es)
MX (1) MX377727B (es)
PL (1) PL3139903T3 (es)
PT (1) PT3139903T (es)
RS (1) RS59383B1 (es)
RU (1) RU2688935C2 (es)
SG (1) SG11201608402WA (es)
SI (1) SI3139903T1 (es)
SM (1) SMT201900525T1 (es)
WO (1) WO2015169728A1 (es)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TR201809633T4 (tr) 2014-05-07 2018-07-23 Bristol Myers Squibb Co Diyabet gibi hastalıkların tedavisine yönelik pirolidin GPR40 modülatörleri.
US9463201B2 (en) 2014-10-19 2016-10-11 M.G. Therapeutics Ltd Compositions and methods for the treatment of meibomian gland dysfunction
FR3039765B1 (fr) * 2015-08-07 2018-08-24 Oreal Procede cosmetique de traitement des matieres keratiniques
CA3000088A1 (en) * 2015-09-28 2017-04-06 Azura Ophthalmics Ltd. Thiol and disulfide-containing agents for increasing meibomian gland lipid secretion
JP2018532753A (ja) * 2015-10-30 2018-11-08 クロマ−ファーマ ゲゼルシャフト エム．ベー．ハー． 滅菌水性点眼液の治療的使用
CA3001634C (en) 2015-10-30 2023-05-23 Croma-Pharma Gesellschaft M.B.H. Therapeutic use of a sterile aqueous ophthalmic solution
JP7154764B2 (ja) * 2015-12-22 2022-10-18 日油株式会社 涙液油層安定化剤およびこれを含有する点眼剤
AU2017250509B2 (en) 2016-04-14 2023-03-02 Azura Ophthalmics Ltd. Selenium disulfide compositions for use in treating meibomian gland dysfunction
ES2650981B2 (es) * 2016-07-20 2018-05-04 Ocupharm Diagnostics, Sl Preparación y uso de un extracto de Artemia salina para tratar la superficie ocular
US10618986B2 (en) * 2016-10-19 2020-04-14 Alcon Inc. Hydrophilic copolymer with pendant thiol groups
AR110125A1 (es) 2016-11-07 2019-02-27 Croma Pharma Ges M B H Compuestos poliméricos que liberan sulfuro de hidrógeno
ES2669446B1 (es) * 2016-11-24 2019-03-13 Saiz Manuel Munoz Producto oftálmico
AU2018247122A1 (en) * 2017-03-29 2019-10-10 Azura Ophthalmics Ltd. Agents for increasing meibomian gland lipid secretion
EP3618803A1 (en) 2017-05-03 2020-03-11 Croma-Pharma GmbH Sterile aqueous ophthalmic solution containing n-(n-acetylcysteinyl)-chitosan for treating non-infectious corneal disorders
KR102472773B1 (ko) * 2018-02-28 2022-11-30 산텐 세이야꾸 가부시키가이샤 디쿠아포솔 및 양이온성 폴리머를 함유하는 안과용 조성물
JP2020075918A (ja) * 2018-11-02 2020-05-21 千寿製薬株式会社 角膜上皮創傷治癒促進用の眼科用組成物
CN109793707B (zh) * 2019-01-30 2022-04-08 温州医科大学 一种透明质酸—n-乙酰半胱氨酸—壳聚糖滴眼液及其制备方法
US20220296485A1 (en) 2019-08-18 2022-09-22 Pmidg, Llc Compositions for sunscreen compounds and methods thereof
TWI848171B (zh) * 2019-08-27 2024-07-11 日商參天製藥股份有限公司 含有迪夸弗索(diquafosol)或其鹽、及聚乙烯吡咯烷酮之水性眼科用組合物
US20210145861A1 (en) * 2019-11-18 2021-05-20 Gregory J. PAMEL Chitosan containing compositions and methods relating to same
WO2021140417A2 (en) 2020-01-10 2021-07-15 Azura Ophthalmics Ltd. Instructions for composition and sensitivity
CN114848670B (zh) * 2022-05-26 2023-06-02 青岛博益特生物材料股份有限公司 一种滴眼液及其制备方法
US20240226180A1 (en) * 2023-01-11 2024-07-11 MAM Holdings of West Florida, L.L.C. Methods and compositions for treating dry eye, tear hyperosmolarity, and other ocular conditions
US20240330778A1 (en) * 2023-04-03 2024-10-03 Halliburton Energy Services, Inc. Borehole holdup prediction using machine learning and pulsed neutron logging tool data

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1258781B (it) 1992-01-16 1996-02-29 Zambon Spa Composizione farmaceutica oftalmica contenente n-acetilcisteina e polivinilalcol
FR2692582B1 (fr) 1992-06-18 1998-09-18 Flamel Tech Sa Nouveaux derives reticulables de collagene, leur procede d'obtention et leur application a la preparation de biomateriaux.
WO1996031195A1 (en) * 1995-04-04 1996-10-10 Otsuka Pharmaceutical Co., Ltd. Package holding a procaterol hydrochloride aqueous solution formulation, and a procaterol hydrochloride aqueous solution formulation
EP0938896A1 (en) * 1998-01-15 1999-09-01 Novartis AG Autoclavable pharmaceutical compositions containing a chelating agent
AT406054B (de) 1998-11-04 2000-02-25 Andreas Bernkop-Schnuerch Verfahren zur verbesserung der mucoadhäsion von polymeren sowie deren herstellung und verwendung
JP2000302803A (ja) 1999-04-22 2000-10-31 Noevir Co Ltd アミノ酸及びペプチドにより遊離アミノ基が選択的に置換され、実質的に水酸基の置換のない部分脱アセチル化キチン・キトサン誘導体、及びその製造方法
ITRM20010438A1 (it) * 2001-07-23 2003-01-23 Farmigea Spa Preparato oftalmico a base di n-acetilcisteina per il trattamento della sindrome dell'occhio secco.
WO2008052037A2 (en) * 2006-10-24 2008-05-02 Alcon Research, Ltd. Packaging materials for formulations containing 2-pyrrolidone derivatives
SI2107913T1 (sl) * 2006-12-22 2012-05-31 Croma Pharma Ges M B H Uporaba tioliranih polisaharidov za tkivno avgmentacijo
WO2008094675A2 (en) 2007-01-31 2008-08-07 Photobiomed Corporation Novel biomaterials and methods for making and using same
US9452592B2 (en) 2007-08-28 2016-09-27 Cryovac, Inc. Multilayer film having an active oxygen barrier layer with radiation enhanced active barrier properties
EP2310002B1 (en) 2008-04-24 2016-11-02 Medtronic, Inc Protective gel based on chitosan and oxidized polysaccharide
US20090269417A1 (en) 2008-04-24 2009-10-29 Medtronic, Inc. Thiolated chitosan gel
EP2296637B1 (en) 2008-04-24 2014-04-02 Medtronic, Inc Chitosan-containing protective composition

Also Published As

Publication number Publication date
US10653620B2 (en) 2020-05-19
BR112016024454B1 (pt) 2023-03-07
CN106456536A (zh) 2017-02-22
MX377727B (es) 2025-03-11
CN106456536B (zh) 2020-05-12
CL2016002815A1 (es) 2017-05-12
KR20170030471A (ko) 2017-03-17
US20170224614A1 (en) 2017-08-10
AU2015257874A1 (en) 2016-10-20
RU2016143341A (ru) 2018-06-07
JP2017514916A (ja) 2017-06-08
RU2016143341A3 (es) 2018-12-25
HUE046425T2 (hu) 2020-02-28
EP3139903B1 (en) 2019-07-03
SI3139903T1 (sl) 2019-10-30
RU2688935C2 (ru) 2019-05-23
US20190269613A1 (en) 2019-09-05
BR112016024454A2 (pt) 2017-08-15
CA2947065C (en) 2022-04-19
RS59383B1 (sr) 2019-11-29
SMT201900525T1 (it) 2019-11-13
PL3139903T3 (pl) 2019-12-31
PT3139903T (pt) 2019-10-24
WO2015169728A1 (en) 2015-11-12
EP3139903A1 (en) 2017-03-15
CY1122122T1 (el) 2020-11-25
MX2016013710A (es) 2017-03-31
US10342759B2 (en) 2019-07-09
KR102378391B1 (ko) 2022-03-24
AU2015257874B2 (en) 2019-11-28
IL248804B (en) 2020-05-31
ES2747808T3 (es) 2020-03-11
HRP20191667T1 (hr) 2019-12-13
SG11201608402WA (en) 2016-11-29
LT3139903T (lt) 2019-09-10
MA39767B1 (fr) 2019-10-31
MA39767A (fr) 2015-11-12
JP6639480B2 (ja) 2020-02-05
CA2947065A1 (en) 2015-11-12
BR112016024454A8 (pt) 2021-06-29
ME03505B (me) 2020-04-20
IL248804A0 (en) 2017-01-31
DK3139903T3 (da) 2019-09-09

Similar Documents

Publication Publication Date Title
MX2016013710A (es) Solucion oftalmica acuosa y metodo para tratar el sindrome del ojo seco.
TR201904455T4 (tr) Nükleer taşıma modülatörleri olarak 1,2,4-triazoller ve bunların kullanımları.
CO6501124A2 (es) Polipeptidos inmunomoduladores derivados se la il 2 y su uso terapeutico en cancer y en infecciones crónicas
UY36465A (es) Compuestos policíclicos de carbamoilpiridona y su uso farmacéutico
BR112018015273A2 (pt) derivados de benzimidazol como moduladores de ror-gama
CO2017005624A2 (es) Composiciones oftálmicas estabilizadas de omega 3
CL2011002543S1 (es) Contenedor de esterilizacion abierto para chupetes, formado por dos prismas truncados huecos, situados uno al lado del otro, que tienen una base rectangular de vertices traseros redondeado y silueta frontal rectangular vertical, su lado superior tiene una curvatura convexa y los lados mayores tienen una hendidura central curva.
UY31785A1 (es) Sistema polimerico de lagrimas artificiales
CL2016002607A1 (es) Procedimiento para preparar una preparación farmacéutica de acetato de glatiramer y manitol en un contenedor adecuado que comprende las etapas de obtener una solución acuosa de acetato de glatiramer y manitol, filtración de la solución entre 0 y 17,5 grado celsius y llenado del contenedor. pct
MX2016013620A (es) Polimeros de (met) acrilamida para lentes de contacto y lentes intraoculares.
MX2018008694A (es) Metodos y composiciones para tratar la hiperhidrosis.
AR102658A1 (es) Composición para el tratamiento de telas
UY36118A (es) Compuestos y composiciones para inducir condrogénesis
BR112018010180A2 (pt) soluções de embalagem de lente de contato
MX2020003049A (es) Semaglutida en la terapia medica.
AR108676A1 (es) Formulaciones inyectables fisiológicamente balanceadas de fosnetupitant
AR092691A1 (es) Composicion farmaceutica que comprende rebamipida
MX2018004779A (es) Uso terapeutico de una solucion oftalmica acuosa esteril.
AR106493A1 (es) Uso terapéutico de una solución oftálmica acuosa estéril
MX377823B (es) Composición nasal con capacidades de formación de película.
EA201892389A1 (ru) Офтальмологическая композиция, содержащая синергическую комбинацию гликогена и гиалуроновой кислоты или ее соли
AR090466A1 (es) Solucion oftalmologica acuosa que contiene ciclosporina
AR107027A1 (es) Moduladores de actividad complementaria
RU2015114205A (ru) Гель-фотосенсибилизатор для фотодинамической терапии
RU2014122049A (ru) Косметическое средство для перманентного макияжа

Legal Events

Date Code Title Description
FB Suspension of granting procedure